Alemtuzumab (Campath) in relapsed or refractory CLL or PLL.
Journal Article
Full Text
Duke Authors
Cited Authors
- McCune, SL; Gockerman, JP; Moore, JO; deCastro, CM; Bass, AJ; Chao, NJ; Long, GD; Vredenburgh, JJ; Gasparetto, C; Adams, DB; Payne, NP; Rizzieri, DA
Published Date
- November 16, 2001
Published In
Volume / Issue
- 98 / 11
Start / End Page
- 290B - 291B
Published By
Pages
- 2
International Standard Serial Number (ISSN)
- 0006-4971
Language
- English